nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—AGTR1—asthma	0.307	1	CbGaD
Irbesartan—PTGS1—Zileuton—asthma	0.0243	0.0604	CbGbCtD
Irbesartan—PTGS1—Zafirlukast—asthma	0.0214	0.0532	CbGbCtD
Irbesartan—CYP2C8—Salmeterol—asthma	0.0157	0.0391	CbGbCtD
Irbesartan—CYP2C8—Mometasone—asthma	0.0157	0.0391	CbGbCtD
Irbesartan—PTGS1—Montelukast—asthma	0.0157	0.0389	CbGbCtD
Irbesartan—CYP2C8—Zafirlukast—asthma	0.0124	0.0307	CbGbCtD
Irbesartan—CYP1A2—Zileuton—asthma	0.0109	0.027	CbGbCtD
Irbesartan—CYP2D6—Ciclesonide—asthma	0.0108	0.0268	CbGbCtD
Irbesartan—CYP2C9—Zileuton—asthma	0.00979	0.0243	CbGbCtD
Irbesartan—CYP1A2—Zafirlukast—asthma	0.00956	0.0238	CbGbCtD
Irbesartan—CYP2C8—Theophylline—asthma	0.00954	0.0237	CbGbCtD
Irbesartan—CYP2C8—Loratadine—asthma	0.00904	0.0225	CbGbCtD
Irbesartan—CYP2C8—Montelukast—asthma	0.00904	0.0225	CbGbCtD
Irbesartan—CYP2D6—Ipratropium bromide—asthma	0.00895	0.0222	CbGbCtD
Irbesartan—CYP2C9—Zafirlukast—asthma	0.00862	0.0214	CbGbCtD
Irbesartan—CYP3A4—Fluticasone furoate—asthma	0.00843	0.0209	CbGbCtD
Irbesartan—CYP2C9—Arformoterol—asthma	0.00832	0.0207	CbGbCtD
Irbesartan—CYP2C9—Formoterol—asthma	0.00832	0.0207	CbGbCtD
Irbesartan—CYP2D6—Zafirlukast—asthma	0.00788	0.0196	CbGbCtD
Irbesartan—CYP1A2—Aminophylline—asthma	0.00785	0.0195	CbGbCtD
Irbesartan—CYP2D6—Arformoterol—asthma	0.00761	0.0189	CbGbCtD
Irbesartan—CYP2D6—Formoterol—asthma	0.00761	0.0189	CbGbCtD
Irbesartan—CYP3A4—Budesonide—asthma	0.00751	0.0187	CbGbCtD
Irbesartan—CYP1A2—Theophylline—asthma	0.00738	0.0183	CbGbCtD
Irbesartan—CYP3A4—Ciclesonide—asthma	0.00687	0.0171	CbGbCtD
Irbesartan—CYP3A4—Indacaterol—asthma	0.00687	0.0171	CbGbCtD
Irbesartan—CYP2D6—Tiotropium—asthma	0.00678	0.0169	CbGbCtD
Irbesartan—CYP2C9—Theophylline—asthma	0.00665	0.0165	CbGbCtD
Irbesartan—CYP3A4—Salbutamol—asthma	0.00639	0.0159	CbGbCtD
Irbesartan—CYP3A4—Salmeterol—asthma	0.00639	0.0159	CbGbCtD
Irbesartan—CYP3A4—Flunisolide—asthma	0.00639	0.0159	CbGbCtD
Irbesartan—CYP2C9—Montelukast—asthma	0.00631	0.0157	CbGbCtD
Irbesartan—CYP2C9—Loratadine—asthma	0.00631	0.0157	CbGbCtD
Irbesartan—CYP2D6—Theophylline—asthma	0.00608	0.0151	CbGbCtD
Irbesartan—CYP2D6—Loratadine—asthma	0.00577	0.0143	CbGbCtD
Irbesartan—CYP3A4—Ipratropium bromide—asthma	0.00569	0.0141	CbGbCtD
Irbesartan—CYP3A4—Zileuton—asthma	0.00569	0.0141	CbGbCtD
Irbesartan—CYP3A4—Fluticasone Propionate—asthma	0.00543	0.0135	CbGbCtD
Irbesartan—CYP2C8—Hydrocortisone—asthma	0.00503	0.0125	CbGbCtD
Irbesartan—CYP3A4—Zafirlukast—asthma	0.00501	0.0124	CbGbCtD
Irbesartan—CYP3A4—Tiotropium—asthma	0.00431	0.0107	CbGbCtD
Irbesartan—CYP3A4—Aminophylline—asthma	0.00411	0.0102	CbGbCtD
Irbesartan—CYP3A4—Theophylline—asthma	0.00387	0.00961	CbGbCtD
Irbesartan—CYP3A4—Montelukast—asthma	0.00367	0.00911	CbGbCtD
Irbesartan—CYP3A4—Loratadine—asthma	0.00367	0.00911	CbGbCtD
Irbesartan—CYP3A4—Methylprednisolone—asthma	0.00335	0.00833	CbGbCtD
Irbesartan—CYP2C8—Dexamethasone—asthma	0.00313	0.00777	CbGbCtD
Irbesartan—CYP3A4—Triamcinolone—asthma	0.00254	0.00632	CbGbCtD
Irbesartan—JUN—exocrine gland—asthma	0.00236	0.1	CbGeAlD
Irbesartan—CYP2C9—Dexamethasone—asthma	0.00218	0.00542	CbGbCtD
Irbesartan—CYP3A4—Betamethasone—asthma	0.00218	0.00542	CbGbCtD
Irbesartan—CYP3A4—Prednisolone—asthma	0.00215	0.00535	CbGbCtD
Irbesartan—CYP3A4—Hydrocortisone—asthma	0.00204	0.00507	CbGbCtD
Irbesartan—CYP3A4—Prednisone—asthma	0.00203	0.00505	CbGbCtD
Irbesartan—CYP2D6—Dexamethasone—asthma	0.002	0.00496	CbGbCtD
Irbesartan—Tasosartan—AGTR2—asthma	0.00147	0.325	CrCbGaD
Irbesartan—CYP3A4—Dexamethasone—asthma	0.00127	0.00315	CbGbCtD
Irbesartan—JUN—respiratory system—asthma	0.00123	0.0521	CbGeAlD
Irbesartan—EDNRA—adrenal cortex—asthma	0.00113	0.0479	CbGeAlD
Irbesartan—EDNRA—bronchus—asthma	0.00111	0.047	CbGeAlD
Irbesartan—JUN—adrenal cortex—asthma	0.00103	0.0437	CbGeAlD
Irbesartan—JUN—epithelium—asthma	0.00103	0.0435	CbGeAlD
Irbesartan—JUN—bronchus—asthma	0.00101	0.0428	CbGeAlD
Irbesartan—EDNRA—trachea—asthma	0.000996	0.0422	CbGeAlD
Irbesartan—JUN—smooth muscle tissue—asthma	0.00099	0.0419	CbGeAlD
Irbesartan—JUN—cardiovascular system—asthma	0.000942	0.0399	CbGeAlD
Irbesartan—JUN—trachea—asthma	0.000909	0.0385	CbGeAlD
Irbesartan—Forasartan—AGTR1—asthma	0.00084	0.186	CrCbGaD
Irbesartan—EDNRA—adrenal gland—asthma	0.000816	0.0346	CbGeAlD
Irbesartan—AGTR1—adrenal cortex—asthma	0.000777	0.0329	CbGeAlD
Irbesartan—AGTR1—epithelium—asthma	0.000774	0.0328	CbGeAlD
Irbesartan—AGTR1—smooth muscle tissue—asthma	0.000746	0.0316	CbGeAlD
Irbesartan—JUN—adrenal gland—asthma	0.000745	0.0315	CbGeAlD
Irbesartan—EDNRA—lung—asthma	0.000716	0.0303	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—asthma	0.000709	0.03	CbGeAlD
Irbesartan—AGTR1—trachea—asthma	0.000684	0.029	CbGeAlD
Irbesartan—JUN—lung—asthma	0.000653	0.0276	CbGeAlD
Irbesartan—AGTR1—adrenal gland—asthma	0.000561	0.0237	CbGeAlD
Irbesartan—Tasosartan—AGTR1—asthma	0.000509	0.113	CrCbGaD
Irbesartan—AGTR1—lung—asthma	0.000492	0.0208	CbGeAlD
Irbesartan—CYP1A2—respiratory system—asthma	0.00047	0.0199	CbGeAlD
Irbesartan—Valsartan—AGTR1—asthma	0.000441	0.0976	CrCbGaD
Irbesartan—Olmesartan—AGTR1—asthma	0.00043	0.0952	CrCbGaD
Irbesartan—PTGS1—respiratory system—asthma	0.000407	0.0172	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—asthma	0.000342	0.0145	CbGeAlD
Irbesartan—PTGS1—epithelium—asthma	0.00034	0.0144	CbGeAlD
Irbesartan—Candesartan—AGTR1—asthma	0.000334	0.074	CrCbGaD
Irbesartan—PTGS1—smooth muscle tissue—asthma	0.000328	0.0139	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—asthma	0.000312	0.0132	CbGeAlD
Irbesartan—PTGS1—trachea—asthma	0.000301	0.0127	CbGeAlD
Irbesartan—CYP1A2—lung—asthma	0.000249	0.0106	CbGeAlD
Irbesartan—PTGS1—adrenal gland—asthma	0.000247	0.0104	CbGeAlD
Irbesartan—PTGS1—lung—asthma	0.000216	0.00915	CbGeAlD
Irbesartan—Losartan—AGTR1—asthma	0.000216	0.0477	CrCbGaD
Irbesartan—JUN—Dexamethasone—Fluticasone furoate—asthma	0.000216	0.0794	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Fluticasone furoate—asthma	0.000216	0.0794	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Fluticasone Propionate—asthma	0.000201	0.074	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Fluticasone Propionate—asthma	0.000201	0.074	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Beclomethasone—asthma	0.000148	0.0544	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Beclomethasone—asthma	0.000148	0.0544	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Budesonide—asthma	0.000142	0.0522	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Budesonide—asthma	0.000142	0.0522	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Flunisolide—asthma	0.00014	0.0515	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Flunisolide—asthma	0.00014	0.0515	CbGdCrCtD
Irbesartan—Losartan—ACE—asthma	0.000125	0.0276	CrCbGaD
Irbesartan—JUN—Dexamethasone—Mometasone—asthma	0.000115	0.0422	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Mometasone—asthma	0.000115	0.0422	CbGdCrCtD
Irbesartan—Valsartan—ALB—asthma	0.000104	0.0231	CrCbGaD
Irbesartan—JUN—Dexamethasone—Hydrocortisone—asthma	7.25e-05	0.0267	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Hydrocortisone—asthma	7.25e-05	0.0267	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Methylprednisolone—asthma	6.84e-05	0.0252	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Methylprednisolone—asthma	6.84e-05	0.0252	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Dexamethasone—asthma	6.73e-05	0.0248	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Betamethasone—asthma	6.73e-05	0.0248	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Triamcinolone—asthma	6.58e-05	0.0242	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—asthma	6.58e-05	0.0242	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisone—asthma	6.24e-05	0.023	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisone—asthma	6.24e-05	0.023	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisolone—asthma	6.09e-05	0.0224	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisolone—asthma	6.09e-05	0.0224	CbGdCrCtD
Irbesartan—Losartan—ALB—asthma	5.1e-05	0.0113	CrCbGaD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.51e-05	0.00016	CcSEcCtD
Irbesartan—Syncope—Triamcinolone—asthma	2.51e-05	0.00016	CcSEcCtD
Irbesartan—Vertigo—Methylprednisolone—asthma	2.51e-05	0.00016	CcSEcCtD
Irbesartan—Syncope—Methylprednisolone—asthma	2.5e-05	0.000159	CcSEcCtD
Irbesartan—Discomfort—Hydrocortisone—asthma	2.5e-05	0.000159	CcSEcCtD
Irbesartan—Connective tissue disorder—Prednisone—asthma	2.5e-05	0.000159	CcSEcCtD
Irbesartan—Nausea—Budesonide—asthma	2.49e-05	0.000159	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisolone—asthma	2.48e-05	0.000158	CcSEcCtD
Irbesartan—Oedema—Prednisolone—asthma	2.48e-05	0.000158	CcSEcCtD
Irbesartan—Loss of consciousness—Triamcinolone—asthma	2.46e-05	0.000157	CcSEcCtD
Irbesartan—Loss of consciousness—Methylprednisolone—asthma	2.45e-05	0.000156	CcSEcCtD
Irbesartan—Shock—Prednisolone—asthma	2.44e-05	0.000156	CcSEcCtD
Irbesartan—Cough—Triamcinolone—asthma	2.44e-05	0.000155	CcSEcCtD
Irbesartan—Anaphylactic shock—Hydrocortisone—asthma	2.43e-05	0.000154	CcSEcCtD
Irbesartan—Oedema—Hydrocortisone—asthma	2.43e-05	0.000154	CcSEcCtD
Irbesartan—Tachycardia—Prednisolone—asthma	2.42e-05	0.000154	CcSEcCtD
Irbesartan—Hypertension—Triamcinolone—asthma	2.42e-05	0.000154	CcSEcCtD
Irbesartan—Hypertension—Methylprednisolone—asthma	2.41e-05	0.000153	CcSEcCtD
Irbesartan—Infection—Hydrocortisone—asthma	2.41e-05	0.000153	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisolone—asthma	2.4e-05	0.000153	CcSEcCtD
Irbesartan—Shock—Hydrocortisone—asthma	2.39e-05	0.000152	CcSEcCtD
Irbesartan—Myalgia—Triamcinolone—asthma	2.38e-05	0.000152	CcSEcCtD
Irbesartan—Nervous system disorder—Hydrocortisone—asthma	2.38e-05	0.000151	CcSEcCtD
Irbesartan—Arthralgia—Methylprednisolone—asthma	2.38e-05	0.000151	CcSEcCtD
Irbesartan—Myalgia—Methylprednisolone—asthma	2.38e-05	0.000151	CcSEcCtD
Irbesartan—Anxiety—Methylprednisolone—asthma	2.37e-05	0.000151	CcSEcCtD
Irbesartan—Tachycardia—Hydrocortisone—asthma	2.37e-05	0.000151	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.36e-05	0.00015	CcSEcCtD
Irbesartan—Flushing—Prednisone—asthma	2.36e-05	0.00015	CcSEcCtD
Irbesartan—Skin disorder—Hydrocortisone—asthma	2.36e-05	0.00015	CcSEcCtD
Irbesartan—Ill-defined disorder—Dexamethasone—asthma	2.36e-05	0.00015	CcSEcCtD
Irbesartan—Ill-defined disorder—Betamethasone—asthma	2.36e-05	0.00015	CcSEcCtD
Irbesartan—Discomfort—Triamcinolone—asthma	2.35e-05	0.00015	CcSEcCtD
Irbesartan—Discomfort—Methylprednisolone—asthma	2.35e-05	0.00015	CcSEcCtD
Irbesartan—Hyperhidrosis—Hydrocortisone—asthma	2.35e-05	0.000149	CcSEcCtD
Irbesartan—Dry mouth—Triamcinolone—asthma	2.33e-05	0.000148	CcSEcCtD
Irbesartan—Angioedema—Dexamethasone—asthma	2.32e-05	0.000148	CcSEcCtD
Irbesartan—Angioedema—Betamethasone—asthma	2.32e-05	0.000148	CcSEcCtD
Irbesartan—Anorexia—Hydrocortisone—asthma	2.31e-05	0.000147	CcSEcCtD
Irbesartan—Angiopathy—Prednisone—asthma	2.31e-05	0.000147	CcSEcCtD
Irbesartan—Immune system disorder—Prednisone—asthma	2.3e-05	0.000146	CcSEcCtD
Irbesartan—Malaise—Dexamethasone—asthma	2.29e-05	0.000146	CcSEcCtD
Irbesartan—Malaise—Betamethasone—asthma	2.29e-05	0.000146	CcSEcCtD
Irbesartan—Oedema—Triamcinolone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Anaphylactic shock—Triamcinolone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Vertigo—Betamethasone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Vertigo—Dexamethasone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Anaphylactic shock—Methylprednisolone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Syncope—Dexamethasone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Syncope—Betamethasone—asthma	2.28e-05	0.000145	CcSEcCtD
Irbesartan—Arrhythmia—Prednisone—asthma	2.27e-05	0.000144	CcSEcCtD
Irbesartan—Infection—Triamcinolone—asthma	2.27e-05	0.000144	CcSEcCtD
Irbesartan—Hypotension—Hydrocortisone—asthma	2.27e-05	0.000144	CcSEcCtD
Irbesartan—Infection—Methylprednisolone—asthma	2.26e-05	0.000144	CcSEcCtD
Irbesartan—Shock—Triamcinolone—asthma	2.25e-05	0.000143	CcSEcCtD
Irbesartan—Shock—Methylprednisolone—asthma	2.24e-05	0.000143	CcSEcCtD
Irbesartan—Nervous system disorder—Methylprednisolone—asthma	2.24e-05	0.000142	CcSEcCtD
Irbesartan—Loss of consciousness—Dexamethasone—asthma	2.23e-05	0.000142	CcSEcCtD
Irbesartan—Loss of consciousness—Betamethasone—asthma	2.23e-05	0.000142	CcSEcCtD
Irbesartan—Paraesthesia—Prednisolone—asthma	2.23e-05	0.000142	CcSEcCtD
Irbesartan—Tachycardia—Triamcinolone—asthma	2.23e-05	0.000142	CcSEcCtD
Irbesartan—Tachycardia—Methylprednisolone—asthma	2.22e-05	0.000142	CcSEcCtD
Irbesartan—Skin disorder—Methylprednisolone—asthma	2.21e-05	0.000141	CcSEcCtD
Irbesartan—Malnutrition—Prednisone—asthma	2.21e-05	0.000141	CcSEcCtD
Irbesartan—Erythema—Prednisone—asthma	2.21e-05	0.000141	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Hydrocortisone—asthma	2.21e-05	0.000141	CcSEcCtD
Irbesartan—Hyperhidrosis—Triamcinolone—asthma	2.21e-05	0.000141	CcSEcCtD
Irbesartan—Hyperhidrosis—Methylprednisolone—asthma	2.2e-05	0.00014	CcSEcCtD
Irbesartan—Hypertension—Dexamethasone—asthma	2.19e-05	0.00014	CcSEcCtD
Irbesartan—Hypertension—Betamethasone—asthma	2.19e-05	0.00014	CcSEcCtD
Irbesartan—Paraesthesia—Hydrocortisone—asthma	2.18e-05	0.000139	CcSEcCtD
Irbesartan—Myalgia—Betamethasone—asthma	2.16e-05	0.000138	CcSEcCtD
Irbesartan—Myalgia—Dexamethasone—asthma	2.16e-05	0.000138	CcSEcCtD
Irbesartan—Anxiety—Betamethasone—asthma	2.15e-05	0.000137	CcSEcCtD
Irbesartan—Anxiety—Dexamethasone—asthma	2.15e-05	0.000137	CcSEcCtD
Irbesartan—Discomfort—Dexamethasone—asthma	2.14e-05	0.000136	CcSEcCtD
Irbesartan—Discomfort—Betamethasone—asthma	2.14e-05	0.000136	CcSEcCtD
Irbesartan—Dyspepsia—Hydrocortisone—asthma	2.14e-05	0.000136	CcSEcCtD
Irbesartan—Hypotension—Methylprednisolone—asthma	2.13e-05	0.000136	CcSEcCtD
Irbesartan—Pain—Prednisolone—asthma	2.12e-05	0.000135	CcSEcCtD
Irbesartan—Decreased appetite—Hydrocortisone—asthma	2.11e-05	0.000134	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Hydrocortisone—asthma	2.09e-05	0.000133	CcSEcCtD
Irbesartan—Fatigue—Hydrocortisone—asthma	2.09e-05	0.000133	CcSEcCtD
Irbesartan—Vision blurred—Prednisone—asthma	2.08e-05	0.000133	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—asthma	2.08e-05	0.000132	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methylprednisolone—asthma	2.08e-05	0.000132	CcSEcCtD
Irbesartan—Pain—Hydrocortisone—asthma	2.07e-05	0.000132	CcSEcCtD
Irbesartan—Anaphylactic shock—Dexamethasone—asthma	2.07e-05	0.000132	CcSEcCtD
Irbesartan—Anaphylactic shock—Betamethasone—asthma	2.07e-05	0.000132	CcSEcCtD
Irbesartan—Oedema—Betamethasone—asthma	2.07e-05	0.000132	CcSEcCtD
Irbesartan—Oedema—Dexamethasone—asthma	2.07e-05	0.000132	CcSEcCtD
Irbesartan—Infection—Betamethasone—asthma	2.06e-05	0.000131	CcSEcCtD
Irbesartan—Infection—Dexamethasone—asthma	2.06e-05	0.000131	CcSEcCtD
Irbesartan—Ill-defined disorder—Prednisone—asthma	2.05e-05	0.000131	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—asthma	2.05e-05	0.000131	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisolone—asthma	2.05e-05	0.00013	CcSEcCtD
Irbesartan—Paraesthesia—Methylprednisolone—asthma	2.05e-05	0.00013	CcSEcCtD
Irbesartan—Anaemia—Prednisone—asthma	2.04e-05	0.00013	CcSEcCtD
Irbesartan—Shock—Betamethasone—asthma	2.04e-05	0.00013	CcSEcCtD
Irbesartan—Shock—Dexamethasone—asthma	2.04e-05	0.00013	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—asthma	2.04e-05	0.00013	CcSEcCtD
Irbesartan—Nervous system disorder—Dexamethasone—asthma	2.03e-05	0.000129	CcSEcCtD
Irbesartan—Nervous system disorder—Betamethasone—asthma	2.03e-05	0.000129	CcSEcCtD
Irbesartan—Agitation—Prednisone—asthma	2.03e-05	0.000129	CcSEcCtD
Irbesartan—Thrombocytopenia—Betamethasone—asthma	2.03e-05	0.000129	CcSEcCtD
Irbesartan—Thrombocytopenia—Dexamethasone—asthma	2.03e-05	0.000129	CcSEcCtD
Irbesartan—Tachycardia—Dexamethasone—asthma	2.02e-05	0.000129	CcSEcCtD
Irbesartan—Tachycardia—Betamethasone—asthma	2.02e-05	0.000129	CcSEcCtD
Irbesartan—Angioedema—Prednisone—asthma	2.02e-05	0.000129	CcSEcCtD
Irbesartan—Dyspepsia—Triamcinolone—asthma	2.01e-05	0.000128	CcSEcCtD
Irbesartan—Dyspepsia—Methylprednisolone—asthma	2.01e-05	0.000128	CcSEcCtD
Irbesartan—Hyperhidrosis—Betamethasone—asthma	2e-05	0.000128	CcSEcCtD
Irbesartan—Hyperhidrosis—Dexamethasone—asthma	2e-05	0.000128	CcSEcCtD
Irbesartan—Feeling abnormal—Hydrocortisone—asthma	2e-05	0.000127	CcSEcCtD
Irbesartan—Malaise—Prednisone—asthma	1.99e-05	0.000127	CcSEcCtD
Irbesartan—Vertigo—Prednisone—asthma	1.99e-05	0.000126	CcSEcCtD
Irbesartan—Gastrointestinal pain—Hydrocortisone—asthma	1.98e-05	0.000126	CcSEcCtD
Irbesartan—Syncope—Prednisone—asthma	1.98e-05	0.000126	CcSEcCtD
Irbesartan—Anorexia—Betamethasone—asthma	1.98e-05	0.000126	CcSEcCtD
Irbesartan—Anorexia—Dexamethasone—asthma	1.98e-05	0.000126	CcSEcCtD
Irbesartan—Urticaria—Prednisolone—asthma	1.97e-05	0.000126	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—asthma	1.97e-05	0.000125	CcSEcCtD
Irbesartan—Fatigue—Methylprednisolone—asthma	1.97e-05	0.000125	CcSEcCtD
Irbesartan—Pain—Triamcinolone—asthma	1.95e-05	0.000124	CcSEcCtD
Irbesartan—Loss of consciousness—Prednisone—asthma	1.94e-05	0.000124	CcSEcCtD
Irbesartan—Hypotension—Dexamethasone—asthma	1.94e-05	0.000123	CcSEcCtD
Irbesartan—Hypotension—Betamethasone—asthma	1.94e-05	0.000123	CcSEcCtD
Irbesartan—Urticaria—Hydrocortisone—asthma	1.93e-05	0.000123	CcSEcCtD
Irbesartan—Abdominal pain—Hydrocortisone—asthma	1.92e-05	0.000122	CcSEcCtD
Irbesartan—Body temperature increased—Hydrocortisone—asthma	1.92e-05	0.000122	CcSEcCtD
Irbesartan—Hypertension—Prednisone—asthma	1.91e-05	0.000122	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dexamethasone—asthma	1.89e-05	0.00012	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Betamethasone—asthma	1.89e-05	0.00012	CcSEcCtD
Irbesartan—Arthralgia—Prednisone—asthma	1.88e-05	0.00012	CcSEcCtD
Irbesartan—Myalgia—Prednisone—asthma	1.88e-05	0.00012	CcSEcCtD
Irbesartan—Feeling abnormal—Triamcinolone—asthma	1.88e-05	0.00012	CcSEcCtD
Irbesartan—Feeling abnormal—Methylprednisolone—asthma	1.88e-05	0.00012	CcSEcCtD
Irbesartan—Anxiety—Prednisone—asthma	1.88e-05	0.000119	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.87e-05	0.000119	CcSEcCtD
Irbesartan—Gastrointestinal pain—Methylprednisolone—asthma	1.86e-05	0.000119	CcSEcCtD
Irbesartan—Paraesthesia—Dexamethasone—asthma	1.86e-05	0.000118	CcSEcCtD
Irbesartan—Paraesthesia—Betamethasone—asthma	1.86e-05	0.000118	CcSEcCtD
Irbesartan—Discomfort—Prednisone—asthma	1.86e-05	0.000118	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisolone—asthma	1.83e-05	0.000116	CcSEcCtD
Irbesartan—Dyspepsia—Dexamethasone—asthma	1.82e-05	0.000116	CcSEcCtD
Irbesartan—Dyspepsia—Betamethasone—asthma	1.82e-05	0.000116	CcSEcCtD
Irbesartan—Urticaria—Triamcinolone—asthma	1.81e-05	0.000116	CcSEcCtD
Irbesartan—Urticaria—Methylprednisolone—asthma	1.81e-05	0.000115	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—asthma	1.81e-05	0.000115	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisone—asthma	1.81e-05	0.000115	CcSEcCtD
Irbesartan—Oedema—Prednisone—asthma	1.81e-05	0.000115	CcSEcCtD
Irbesartan—Abdominal pain—Methylprednisolone—asthma	1.8e-05	0.000115	CcSEcCtD
Irbesartan—Decreased appetite—Dexamethasone—asthma	1.8e-05	0.000115	CcSEcCtD
Irbesartan—Decreased appetite—Betamethasone—asthma	1.8e-05	0.000115	CcSEcCtD
Irbesartan—Infection—Prednisone—asthma	1.79e-05	0.000114	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Dexamethasone—asthma	1.79e-05	0.000114	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betamethasone—asthma	1.79e-05	0.000114	CcSEcCtD
Irbesartan—Hypersensitivity—Hydrocortisone—asthma	1.79e-05	0.000114	CcSEcCtD
Irbesartan—Fatigue—Dexamethasone—asthma	1.79e-05	0.000114	CcSEcCtD
Irbesartan—Fatigue—Betamethasone—asthma	1.79e-05	0.000114	CcSEcCtD
Irbesartan—Shock—Prednisone—asthma	1.78e-05	0.000113	CcSEcCtD
Irbesartan—Pain—Betamethasone—asthma	1.77e-05	0.000113	CcSEcCtD
Irbesartan—Pain—Dexamethasone—asthma	1.77e-05	0.000113	CcSEcCtD
Irbesartan—Nervous system disorder—Prednisone—asthma	1.77e-05	0.000113	CcSEcCtD
Irbesartan—Tachycardia—Prednisone—asthma	1.76e-05	0.000112	CcSEcCtD
Irbesartan—Skin disorder—Prednisone—asthma	1.75e-05	0.000112	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisone—asthma	1.75e-05	0.000111	CcSEcCtD
Irbesartan—Asthenia—Hydrocortisone—asthma	1.74e-05	0.000111	CcSEcCtD
Irbesartan—Anorexia—Prednisone—asthma	1.72e-05	0.00011	CcSEcCtD
Irbesartan—Pruritus—Hydrocortisone—asthma	1.72e-05	0.000109	CcSEcCtD
Irbesartan—Feeling abnormal—Betamethasone—asthma	1.71e-05	0.000109	CcSEcCtD
Irbesartan—Feeling abnormal—Dexamethasone—asthma	1.71e-05	0.000109	CcSEcCtD
Irbesartan—Gastrointestinal pain—Betamethasone—asthma	1.7e-05	0.000108	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dexamethasone—asthma	1.7e-05	0.000108	CcSEcCtD
Irbesartan—Hypersensitivity—Triamcinolone—asthma	1.68e-05	0.000107	CcSEcCtD
Irbesartan—Hypersensitivity—Methylprednisolone—asthma	1.68e-05	0.000107	CcSEcCtD
Irbesartan—Diarrhoea—Hydrocortisone—asthma	1.66e-05	0.000106	CcSEcCtD
Irbesartan—Urticaria—Betamethasone—asthma	1.65e-05	0.000105	CcSEcCtD
Irbesartan—Urticaria—Dexamethasone—asthma	1.65e-05	0.000105	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Prednisone—asthma	1.64e-05	0.000105	CcSEcCtD
Irbesartan—Dizziness—Prednisolone—asthma	1.64e-05	0.000105	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—asthma	1.64e-05	0.000104	CcSEcCtD
Irbesartan—Body temperature increased—Dexamethasone—asthma	1.64e-05	0.000104	CcSEcCtD
Irbesartan—Abdominal pain—Dexamethasone—asthma	1.64e-05	0.000104	CcSEcCtD
Irbesartan—Abdominal pain—Betamethasone—asthma	1.64e-05	0.000104	CcSEcCtD
Irbesartan—Body temperature increased—Betamethasone—asthma	1.64e-05	0.000104	CcSEcCtD
Irbesartan—Asthenia—Methylprednisolone—asthma	1.64e-05	0.000104	CcSEcCtD
Irbesartan—Paraesthesia—Prednisone—asthma	1.62e-05	0.000103	CcSEcCtD
Irbesartan—Pruritus—Triamcinolone—asthma	1.62e-05	0.000103	CcSEcCtD
Irbesartan—Pruritus—Methylprednisolone—asthma	1.61e-05	0.000103	CcSEcCtD
Irbesartan—Dizziness—Hydrocortisone—asthma	1.6e-05	0.000102	CcSEcCtD
Irbesartan—Dyspepsia—Prednisone—asthma	1.59e-05	0.000101	CcSEcCtD
Irbesartan—Decreased appetite—Prednisone—asthma	1.57e-05	9.99e-05	CcSEcCtD
Irbesartan—Rash—Prednisolone—asthma	1.57e-05	9.97e-05	CcSEcCtD
Irbesartan—Dermatitis—Prednisolone—asthma	1.56e-05	9.96e-05	CcSEcCtD
Irbesartan—Diarrhoea—Methylprednisolone—asthma	1.56e-05	9.93e-05	CcSEcCtD
Irbesartan—Fatigue—Prednisone—asthma	1.56e-05	9.91e-05	CcSEcCtD
Irbesartan—Headache—Prednisolone—asthma	1.56e-05	9.9e-05	CcSEcCtD
Irbesartan—Constipation—Prednisone—asthma	1.54e-05	9.82e-05	CcSEcCtD
Irbesartan—Vomiting—Hydrocortisone—asthma	1.54e-05	9.82e-05	CcSEcCtD
Irbesartan—Rash—Hydrocortisone—asthma	1.53e-05	9.74e-05	CcSEcCtD
Irbesartan—Dermatitis—Hydrocortisone—asthma	1.53e-05	9.73e-05	CcSEcCtD
Irbesartan—Headache—Hydrocortisone—asthma	1.52e-05	9.67e-05	CcSEcCtD
Irbesartan—Dizziness—Triamcinolone—asthma	1.51e-05	9.61e-05	CcSEcCtD
Irbesartan—Dizziness—Methylprednisolone—asthma	1.51e-05	9.59e-05	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisone—asthma	1.49e-05	9.47e-05	CcSEcCtD
Irbesartan—Asthenia—Dexamethasone—asthma	1.49e-05	9.47e-05	CcSEcCtD
Irbesartan—Asthenia—Betamethasone—asthma	1.49e-05	9.47e-05	CcSEcCtD
Irbesartan—Gastrointestinal pain—Prednisone—asthma	1.48e-05	9.39e-05	CcSEcCtD
Irbesartan—Nausea—Prednisolone—asthma	1.48e-05	9.39e-05	CcSEcCtD
Irbesartan—Pruritus—Betamethasone—asthma	1.47e-05	9.33e-05	CcSEcCtD
Irbesartan—Pruritus—Dexamethasone—asthma	1.47e-05	9.33e-05	CcSEcCtD
Irbesartan—Vomiting—Triamcinolone—asthma	1.45e-05	9.24e-05	CcSEcCtD
Irbesartan—Vomiting—Methylprednisolone—asthma	1.45e-05	9.22e-05	CcSEcCtD
Irbesartan—Nausea—Hydrocortisone—asthma	1.44e-05	9.17e-05	CcSEcCtD
Irbesartan—Rash—Triamcinolone—asthma	1.44e-05	9.17e-05	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—asthma	1.44e-05	9.16e-05	CcSEcCtD
Irbesartan—Rash—Methylprednisolone—asthma	1.44e-05	9.15e-05	CcSEcCtD
Irbesartan—Dermatitis—Methylprednisolone—asthma	1.44e-05	9.14e-05	CcSEcCtD
Irbesartan—Urticaria—Prednisone—asthma	1.43e-05	9.13e-05	CcSEcCtD
Irbesartan—Headache—Triamcinolone—asthma	1.43e-05	9.11e-05	CcSEcCtD
Irbesartan—Headache—Methylprednisolone—asthma	1.43e-05	9.09e-05	CcSEcCtD
Irbesartan—Abdominal pain—Prednisone—asthma	1.43e-05	9.08e-05	CcSEcCtD
Irbesartan—Body temperature increased—Prednisone—asthma	1.43e-05	9.08e-05	CcSEcCtD
Irbesartan—Diarrhoea—Dexamethasone—asthma	1.42e-05	9.03e-05	CcSEcCtD
Irbesartan—Diarrhoea—Betamethasone—asthma	1.42e-05	9.03e-05	CcSEcCtD
Irbesartan—Dizziness—Dexamethasone—asthma	1.37e-05	8.72e-05	CcSEcCtD
Irbesartan—Dizziness—Betamethasone—asthma	1.37e-05	8.72e-05	CcSEcCtD
Irbesartan—Nausea—Triamcinolone—asthma	1.36e-05	8.64e-05	CcSEcCtD
Irbesartan—Nausea—Methylprednisolone—asthma	1.35e-05	8.62e-05	CcSEcCtD
Irbesartan—Hypersensitivity—Prednisone—asthma	1.33e-05	8.46e-05	CcSEcCtD
Irbesartan—Vomiting—Dexamethasone—asthma	1.32e-05	8.39e-05	CcSEcCtD
Irbesartan—Vomiting—Betamethasone—asthma	1.32e-05	8.39e-05	CcSEcCtD
Irbesartan—Rash—Dexamethasone—asthma	1.31e-05	8.32e-05	CcSEcCtD
Irbesartan—Rash—Betamethasone—asthma	1.31e-05	8.32e-05	CcSEcCtD
Irbesartan—Dermatitis—Betamethasone—asthma	1.31e-05	8.31e-05	CcSEcCtD
Irbesartan—Dermatitis—Dexamethasone—asthma	1.31e-05	8.31e-05	CcSEcCtD
Irbesartan—Headache—Betamethasone—asthma	1.3e-05	8.26e-05	CcSEcCtD
Irbesartan—Headache—Dexamethasone—asthma	1.3e-05	8.26e-05	CcSEcCtD
Irbesartan—Asthenia—Prednisone—asthma	1.3e-05	8.24e-05	CcSEcCtD
Irbesartan—Pruritus—Prednisone—asthma	1.28e-05	8.13e-05	CcSEcCtD
Irbesartan—Diarrhoea—Prednisone—asthma	1.24e-05	7.86e-05	CcSEcCtD
Irbesartan—Nausea—Dexamethasone—asthma	1.23e-05	7.84e-05	CcSEcCtD
Irbesartan—Nausea—Betamethasone—asthma	1.23e-05	7.84e-05	CcSEcCtD
Irbesartan—Dizziness—Prednisone—asthma	1.19e-05	7.6e-05	CcSEcCtD
Irbesartan—Vomiting—Prednisone—asthma	1.15e-05	7.3e-05	CcSEcCtD
Irbesartan—Rash—Prednisone—asthma	1.14e-05	7.24e-05	CcSEcCtD
Irbesartan—Dermatitis—Prednisone—asthma	1.14e-05	7.24e-05	CcSEcCtD
Irbesartan—Headache—Prednisone—asthma	1.13e-05	7.2e-05	CcSEcCtD
Irbesartan—Nausea—Prednisone—asthma	1.07e-05	6.82e-05	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—asthma	6.16e-06	6.03e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PPP2CA—asthma	6.13e-06	6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	6.02e-06	5.9e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—asthma	6.01e-06	5.9e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—asthma	6e-06	5.88e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—asthma	5.99e-06	5.87e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KNG1—asthma	5.96e-06	5.85e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—asthma	5.94e-06	5.83e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—ICAM1—asthma	5.94e-06	5.82e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AGTR1—asthma	5.93e-06	5.81e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2RA—asthma	5.93e-06	5.81e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—asthma	5.88e-06	5.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—C3—asthma	5.88e-06	5.76e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALDH7A1—asthma	5.88e-06	5.76e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—asthma	5.86e-06	5.75e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6R—asthma	5.84e-06	5.73e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALDH7A1—asthma	5.83e-06	5.71e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—asthma	5.79e-06	5.68e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—EGFR—asthma	5.73e-06	5.62e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PDGFB—asthma	5.72e-06	5.61e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALOX15—asthma	5.69e-06	5.57e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALOX5AP—asthma	5.69e-06	5.57e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NTRK1—asthma	5.68e-06	5.57e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ARG2—asthma	5.63e-06	5.52e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADRB2—asthma	5.63e-06	5.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LTC4S—asthma	5.61e-06	5.5e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ARG2—asthma	5.59e-06	5.48e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ARG1—asthma	5.51e-06	5.4e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SERPINE1—asthma	5.47e-06	5.36e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LEP—asthma	5.47e-06	5.36e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CHAT—asthma	5.43e-06	5.32e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NQO1—asthma	5.41e-06	5.31e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ITPR1—asthma	5.32e-06	5.22e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6R—asthma	5.3e-06	5.19e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADCY2—asthma	5.3e-06	5.19e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RHOA—asthma	5.28e-06	5.17e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—EGFR—asthma	5.27e-06	5.17e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.25e-06	5.15e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—asthma	5.22e-06	5.12e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—asthma	5.21e-06	5.1e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FN1—asthma	5.16e-06	5.06e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD86—asthma	5.07e-06	4.97e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EDN1—asthma	5.03e-06	4.93e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL5—asthma	4.99e-06	4.89e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDH7A1—asthma	4.98e-06	4.88e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PLA2G4A—asthma	4.97e-06	4.87e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CSF2—asthma	4.91e-06	4.82e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	4.9e-06	4.8e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LTA4H—asthma	4.86e-06	4.76e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALOX5—asthma	4.84e-06	4.74e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SMAD3—asthma	4.78e-06	4.69e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ARG2—asthma	4.77e-06	4.68e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—asthma	4.75e-06	4.65e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—asthma	4.7e-06	4.61e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALOX15—asthma	4.67e-06	4.58e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALOX5AP—asthma	4.67e-06	4.58e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—asthma	4.63e-06	4.54e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALOX5AP—asthma	4.63e-06	4.54e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALOX15—asthma	4.63e-06	4.54e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CARM1—asthma	4.61e-06	4.52e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—asthma	4.6e-06	4.51e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6R—asthma	4.59e-06	4.49e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—asthma	4.58e-06	4.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PPP2CA—asthma	4.58e-06	4.49e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—BCL2—asthma	4.56e-06	4.47e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DCN—asthma	4.55e-06	4.46e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—asthma	4.54e-06	4.45e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—asthma	4.52e-06	4.43e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTP1—asthma	4.51e-06	4.42e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EGFR—asthma	4.5e-06	4.41e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—asthma	4.49e-06	4.4e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CHAT—asthma	4.45e-06	4.37e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HMOX1—asthma	4.45e-06	4.36e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ITPR1—asthma	4.44e-06	4.35e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—asthma	4.43e-06	4.34e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2RA—asthma	4.43e-06	4.34e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALDH2—asthma	4.42e-06	4.34e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CHAT—asthma	4.42e-06	4.33e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—asthma	4.41e-06	4.32e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAT—asthma	4.39e-06	4.31e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—C3—asthma	4.39e-06	4.3e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—asthma	4.36e-06	4.28e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SERPINE1—asthma	4.29e-06	4.21e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PDGFB—asthma	4.27e-06	4.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	4.25e-06	4.17e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ARG1—asthma	4.25e-06	4.16e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTT1—asthma	4.21e-06	4.12e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—asthma	4.19e-06	4.11e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	4.18e-06	4.1e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTEN—asthma	4.17e-06	4.08e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—asthma	4.15e-06	4.07e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLA2G4A—asthma	4.15e-06	4.07e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTM1—asthma	4.15e-06	4.07e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RHOA—asthma	4.14e-06	4.06e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—asthma	4.1e-06	4.02e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LEP—asthma	4.09e-06	4.01e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—asthma	4.05e-06	3.97e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—asthma	4.03e-06	3.95e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—asthma	4.02e-06	3.94e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALOX5—asthma	3.97e-06	3.89e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALOX5AP—asthma	3.96e-06	3.88e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALOX15—asthma	3.96e-06	3.88e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALOX5—asthma	3.94e-06	3.86e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	3.88e-06	3.8e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FN1—asthma	3.86e-06	3.78e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDH7A1—asthma	3.84e-06	3.77e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPP2CA—asthma	3.82e-06	3.74e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CARM1—asthma	3.79e-06	3.71e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTEN—asthma	3.78e-06	3.7e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CHAT—asthma	3.77e-06	3.7e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—asthma	3.76e-06	3.69e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CARM1—asthma	3.75e-06	3.68e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DCN—asthma	3.73e-06	3.66e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—STAT3—asthma	3.73e-06	3.65e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DCN—asthma	3.7e-06	3.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ARG2—asthma	3.68e-06	3.61e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—asthma	3.64e-06	3.56e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALDH2—asthma	3.63e-06	3.56e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTEN—asthma	3.62e-06	3.55e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALDH2—asthma	3.6e-06	3.53e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—asthma	3.51e-06	3.44e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NQO1—asthma	3.5e-06	3.43e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—asthma	3.48e-06	3.41e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	3.46e-06	3.39e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—asthma	3.46e-06	3.39e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—asthma	3.45e-06	3.39e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTT1—asthma	3.45e-06	3.39e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—asthma	3.44e-06	3.37e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6R—asthma	3.43e-06	3.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTT1—asthma	3.42e-06	3.36e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADCY2—asthma	3.42e-06	3.35e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.39e-06	3.32e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EGFR—asthma	3.39e-06	3.32e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—STAT3—asthma	3.38e-06	3.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALOX5—asthma	3.36e-06	3.3e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—asthma	3.29e-06	3.22e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTEN—asthma	3.27e-06	3.21e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CARM1—asthma	3.21e-06	3.14e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—asthma	3.21e-06	3.14e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DCN—asthma	3.16e-06	3.1e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	3.16e-06	3.09e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RHOA—asthma	3.09e-06	3.03e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDH2—asthma	3.08e-06	3.01e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—EGFR—asthma	3.07e-06	3.01e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—asthma	3.06e-06	3e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALOX5AP—asthma	3.05e-06	2.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALOX15—asthma	3.05e-06	2.99e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	2.96e-06	2.9e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	2.96e-06	2.9e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—asthma	2.95e-06	2.9e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—asthma	2.93e-06	2.87e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTT1—asthma	2.93e-06	2.87e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT3—asthma	2.92e-06	2.87e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTP1—asthma	2.92e-06	2.86e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CHAT—asthma	2.91e-06	2.85e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMOX1—asthma	2.88e-06	2.82e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NQO1—asthma	2.87e-06	2.81e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ITPR1—asthma	2.87e-06	2.81e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NQO1—asthma	2.85e-06	2.79e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—asthma	2.84e-06	2.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADCY2—asthma	2.81e-06	2.75e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADCY2—asthma	2.78e-06	2.73e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.76e-06	2.71e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—asthma	2.72e-06	2.66e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—asthma	2.71e-06	2.66e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	2.7e-06	2.64e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—asthma	2.68e-06	2.63e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLA2G4A—asthma	2.68e-06	2.63e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—asthma	2.67e-06	2.62e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EGFR—asthma	2.66e-06	2.61e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—asthma	2.6e-06	2.55e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—asthma	2.6e-06	2.55e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALOX5—asthma	2.6e-06	2.54e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—asthma	2.56e-06	2.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CARM1—asthma	2.48e-06	2.43e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPP2CA—asthma	2.47e-06	2.42e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—asthma	2.46e-06	2.41e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTEN—asthma	2.44e-06	2.39e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DCN—asthma	2.44e-06	2.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NQO1—asthma	2.43e-06	2.38e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	2.41e-06	2.36e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTP1—asthma	2.39e-06	2.35e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADCY2—asthma	2.38e-06	2.33e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDH2—asthma	2.37e-06	2.33e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTP1—asthma	2.37e-06	2.33e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMOX1—asthma	2.36e-06	2.31e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—asthma	2.36e-06	2.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.36e-06	2.31e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ITPR1—asthma	2.36e-06	2.31e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMOX1—asthma	2.34e-06	2.29e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—asthma	2.34e-06	2.29e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ITPR1—asthma	2.34e-06	2.29e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—asthma	2.33e-06	2.28e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—asthma	2.31e-06	2.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTT1—asthma	2.26e-06	2.21e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—asthma	2.21e-06	2.16e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G4A—asthma	2.2e-06	2.16e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—asthma	2.2e-06	2.16e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT3—asthma	2.18e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—asthma	2.18e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G4A—asthma	2.18e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	2.06e-06	2.02e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—asthma	2.04e-06	2e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTEN—asthma	2.04e-06	2e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTP1—asthma	2.03e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPP2CA—asthma	2.03e-06	1.99e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—asthma	2.03e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPP2CA—asthma	2.01e-06	1.97e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMOX1—asthma	2e-06	1.96e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ITPR1—asthma	2e-06	1.96e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EGFR—asthma	1.99e-06	1.95e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—asthma	1.97e-06	1.93e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—asthma	1.89e-06	1.86e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NQO1—asthma	1.88e-06	1.84e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G4A—asthma	1.86e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—asthma	1.86e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADCY2—asthma	1.84e-06	1.8e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—asthma	1.73e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPP2CA—asthma	1.72e-06	1.68e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—asthma	1.65e-06	1.62e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTP1—asthma	1.57e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—asthma	1.55e-06	1.52e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMOX1—asthma	1.54e-06	1.51e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—asthma	1.54e-06	1.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ITPR1—asthma	1.54e-06	1.51e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—asthma	1.53e-06	1.5e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—asthma	1.52e-06	1.49e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—asthma	1.51e-06	1.48e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G4A—asthma	1.44e-06	1.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—asthma	1.44e-06	1.41e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—asthma	1.42e-06	1.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—asthma	1.41e-06	1.38e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—asthma	1.36e-06	1.33e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—asthma	1.34e-06	1.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPP2CA—asthma	1.32e-06	1.3e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTEN—asthma	1.32e-06	1.29e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—asthma	1.32e-06	1.29e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—asthma	1.24e-06	1.22e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—asthma	1.23e-06	1.21e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—asthma	1.2e-06	1.18e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—asthma	1.15e-06	1.13e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTEN—asthma	1.08e-06	1.06e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTEN—asthma	1.07e-06	1.05e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—asthma	1.05e-06	1.03e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—asthma	1.02e-06	9.96e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—asthma	9.27e-07	9.08e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTEN—asthma	9.16e-07	8.98e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—asthma	8.87e-07	8.69e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—asthma	8.11e-07	7.95e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTEN—asthma	7.07e-07	6.93e-06	CbGpPWpGaD
